Bristol-Myers Squibb

BDR Pharma Applies for CL for Anti-Cancer Drug

BDR Pharma Applies for CL for Anti-Cancer Drug

An anti-cancer drug by American drug giant Bristol-Myers Squibb (BMS) is needed to go on sales. It is, therefore, that a compulsory license (CL) for the same has been applied for by a pharma firm based in Mumbai.

An executive from BDR Pharma said on Monday that the application for sales of BMS's Dasatanib at a very low price had been submitted by them.